Erlonat 150mg

Erlonat 150 mg is a cancer medicine containing Erlotinib, which falls into the category of drugs known as EGFR inhibitors. The medication blocks the action of EGFR’s that can be found on the surface of some tumour cells. As a result of this blockage, the cancer cells no longer receive the message needed for growth and spreading of the disease. Erlotinib helps to stop cancer from growing, progressing, and spreading through the body. Erlonat tablets is a prescription medicine for non-small cell lung cancer (NSCLC) of advanced stage. Anti-cancer therapy is also effective in patients with pancreatic cancer.